相关实验视频
Updated: Mar 14, 2026

08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
69.2K
IBD研究和治疗的当前和未来方面:2022年前景
1Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany.
Frontiers in gastroenterology (Lausanne, Switzerland)
|March 13, 2026
概括
目前针对免疫反应的炎症性肠病 (IBD) 治疗方法经常失败. 对粘膜膜抗菌屏障的新关注为克罗恩病和性结肠炎的治疗提供了潜在的途径.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 药物开发 药物开发
背景情况:
- 炎症性肠道疾病 (IBD) 的发病历史上被视为对肠道微生物群的免疫"超越".
- 目前的疗法针对的是TNF,IL12/23,α4ß7整体和Janus激酶等免疫媒介,在实现深度缓解和粘膜愈合方面取得的成功有限.
- 最近的方法包括斯芬戈-1受体激动剂,以减少淋巴细胞贩运.
研究的目的:
- 审查IBD病原和治疗中的过去,现在和未来的概念.
- 要突出重点从免疫调节到粘膜抗菌屏障的转变.
- 探索新的治疗策略,以实现IBD的潜在治疗方法.
主要方法:
- 关于IBD病原和治疗策略的文献综述.
- 分析当前的治疗目标及其局限性.
- 讨论以粘膜屏障为重点的新兴概念.
主要成果:
- 现有的免疫调节疗法往往无法在IBD患者中诱导长期缓解和粘膜愈合.
- 正在出现一种向理解和准粘膜抗菌屏障的范式转变.
- 这种新的方法可能提供一种更有效的策略来阻止疾病的进展.
结论:
- 目前仅专注于免疫抑制的IBD治疗方法不足以治愈.
- 解决粘膜抗菌屏障的完整性对于未来IBD疗法至关重要.
- 针对细菌进入和免疫反应的协调方法可能会导致IBD的治愈.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
998
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
998
Inflammatory Bowel Disease IV: Pharmacological Management
893
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
893
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease V: Surgical Management
800
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
800
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
636
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
636

